Previous 10 | Next 10 |
Presentation Times and Weblinks Released for Over 60 Presenting Companies Today: Thursday, November 19, 2020 NEW YORK, NY / ACCESSWIRE / November 19, 2020 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for today's Virtual Microc...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be presenti...
Video Games Played via MyoPro for Training, Rehabilitation and Fun Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company offering increased functionality for individuals suffering from neurologica...
Gainers: Five Prime Therapeutics (FPRX) +259%.Fuel Tech (FTEK) +96%.Equillium (EQ) +61%.Immuron (IMRN) +29%.Genfit (GNFT) +27%.Performance Shipping (PSHG) +25%.Revlon (REV) +21%.Eastside Distilling (EAST) +20%.Vaxart (VXRT) +20%.Myomo (MYO) +19%.Losers: eGain (EGAN) -29%.S...
Myomo, Inc. (MYO) Q3 2020 Earnings Conference Call November 10, 2020, 04:30 PM ET Company Participants Kim Golodetz - SVP and Principal, LHA, IR Paul Gudonis - CEO Dave Henry - CFO Conference Call Participants Kyle Bauser - Colliers Securities Scott Henry - ROTH Capital Edward Woo - Ascendian...
Myomo (MYO): Q3 GAAP EPS of -$0.70 beats by $0.35.Revenue of $1.93M (+216.4% Y/Y) beats by $0.76M.Press Release For further details see: Myomo EPS beats by $0.35, beats on revenue
Authorization backlog at a record 162 units, up 35% sequentially Cash utilization of $1.8 million, lowest since scale-up activities began in 2018 Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MYO) (“Myomo”...
Management to host Financial Results Conference Call at 4:30 p.m. ET Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological dis...
Myomo (MYO) appoints experienced physician, author and executive, Harry Kovelman, as its Chief Medical Officer, effective November 2. In this role, Dr. Kovelman will oversee Myomo’s patient advocacy organization, which helps ensure MyoPro patients’ clinical qualification fo...
Experienced Physician, Author and Executive to Join Senior Leadership Team Myomo, Inc. (NYSE American:MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurolo...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 17:00:05 ET Scott Henry from Industrial Alliance Securities issued a price target of $5.75 for MYO on 2024-07-10 15:33:00. The adjusted price target was set to $5.75. At the time of the announcement, MYO was trading at $4.97. The overall price target consensus...
2024-07-10 16:15:02 ET Alliance Global Partners analyst issues BUY recommendation for MYO on July 10, 2024 03:33PM ET. The previous analyst recommendation was Buy. MYO was trading at $4.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-09 10:30:11 ET Lake Street analyst issues BUY recommendation for MYO on July 9, 2024 08:45AM ET. The previous analyst recommendation was Buy. MYO was trading at $4.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...